Profile data is unavailable for this security.
About the company
Rapid Therapeutic Science Laboratories, Inc. is a biopharmaceutical company. The Company is focused on developing potential commercial opportunities which involve the rapid application of therapeutics using inhaler technology. The Company has developed a method of formulating and manufacturing pressurized metered dose inhalers (pMDI) that contain and properly aerosolize proprietary formula of one or more patent pending pharmaceutical-grade cannabinoid compounds. It has developed and is continuing to develop a series of complementary products in addition to its inhaler. It is also focusing on manufacturing its own branded MDI under the nhaler brand name.
- Revenue in USD (TTM)0.00
- Net income in USD59.55k
- Incorporated2013
- Employees3.00
- LocationRapid Therapeutic Science Laboratories Inc558 County Road 472DE LEON 76444United StatesUSA
- Phone+1 (214) 236-1363
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bloomios Inc | 8.23m | -40.32m | 58.03k | 30.00 | -- | -- | -- | 0.007 | -1.30 | -1.30 | 0.2615 | -0.5118 | 3.18 | 50.02 | 38.61 | -- | -1,557.22 | -- | -- | -- | 24.96 | -- | -489.86 | -- | 0.0105 | -0.4335 | -- | -- | -28.43 | -- | -584.83 | -- | -- | -- |
| Rapid Therapeutic Science Laborators Inc | 0.00 | 59.55k | 104.55k | 3.00 | 0.8518 | -- | 0.9979 | -- | 0.0059 | 0.0059 | 0.00 | -0.3101 | 0.00 | 0.00 | -- | 0.00 | 2.64 | -- | -- | -- | -- | -- | -- | -- | 0.0323 | -0.9303 | 4.87 | -- | -100.00 | -- | 37.42 | -- | -- | -- |
| Black Bird Biotech Inc | 36.33k | -836.14k | 147.61k | 4.00 | -- | -- | -- | 4.06 | -0.0018 | -0.0018 | 0.00005 | -0.0005 | 0.2718 | 0.3178 | 13.31 | 9,082.50 | -625.64 | -433.36 | -- | -- | 27.55 | -- | -2,301.51 | -1,800.06 | 0.0154 | -0.6032 | -- | -- | -20.96 | -- | 8.42 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to Rapid Therapeutic Science Laboratories Inc's reporting currency: US Dollar USD
16.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2023 | 1.49m | 16.88% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
